Professional resources
British Menopause Society.
BMS Links
BMS Tools for Clinician https://thebms.org.uk/publications/tools-for-clinicians/
BMS Tools for Clinician https://thebms.org.uk/publications/tools-for-clinicians/
- What is the menopause? (PDF, 115KB)
- Menopause practice standards (PDF, 320KB)
- NICE: Menopause, Diagnosis and Management – from Guideline to Practice Guideline Summary (PDF, 80KB)
- Menopause: Guidance for Practice Top Ten Tips (PDF, 70KB)
- HRT Guide (PDF, 144KB)
- HRT – Practical prescribing (PDF, 110KB)
- HRT preparations and equivalent alternatives (PDF, 112KB)
- Progestogens and endometrial protection (PDF, 155KB)
- Fast Facts: HRT and breast cancer risk (PDF, 84KB)
- Prescribable alternatives to HRT (PDF, 88KB)
- Testosterone replacement in menopause
- Cognitive Behaviour Therapy (CBT) for Menopausal Symptoms (PDF, 103KB)
- Surgical Menopause (PDF, 124KB)
- Induced menopause in women with endometriosis (PDF, 109KB)
- Migraine and HRT
- HIV and the menopause (PDF, 81KB)
- Menopause and the Workplace Guidance: what to consider (PDF, 111KB)
Louise Newson - Newson Health
https://www.fourteenfish.com/resource/index/1711
Booklets & Fact sheets
HRT
Journal publications
Menopause and perimenopause
2016 IMS Recommendations on women's midlife health and menopause hormone therapy
Bioidentical Menopausal Hormone Therapy: Registered Hormones (non-oral estradiol?±?progesterone) are
BMS and WHC 2016 recommendations on HRT in menopausal women
Consensus statement for non-hormonal based treatments for menopausal symptoms
Dietary intake and menopausal symptoms in postmenopausal women: a systematic review
Effectiveness of transdermal oestradiol and natural micronised progesterone for menopausal symptoms
EMAS position statement: Non-hormonal management of menopausal vasomotor symptoms
Menopause Diagnosis and Management - NICE Guideline NG23
The effects of menopause transition on women’s economic participation in the UK
Work outcomes in midlife women: the impact of menopause, work stress and working environment
Breast cancer risk
HRT and breast cancer risk
HRT and breast cancer risk - Fast facts
HRT Myths Uncovered - Primary Care Women's Health Forum - May-2018
HRT optimization, using transdermal estradiol plus micronized progesterone, a safer HRT
Managing vasomotor symptoms effectively without hormones
Menopausal hormone therapy: a better and safer future
Menopause Diagnosis and Management - NICE Guideline NG23
Postmenopausal hormone replacement therapy and cardiovascular disease: the value of transdermal estradiol and micronized progesterone The impact of micronized progesterone on breast cancer risk: a systematic review
Use of hormone replacement therapy and risk of venous thromboembolism: nested case-control studies using the QR esearch and CPRD databases
Prescribing
Bioidentical Menopausal Hormone Therapy: Registered Hormones (non-oral estradiol?±?progesterone) are
BMS - Consensus statement: Bioidentical HRT
Custom-compounded bioidentical hormone therapy: why so popular despite potential harm? The case against routine use
Easy HRT prescribing guide 2020
Effectiveness of transdermal oestradiol and natural micronised progesterone for menopausal symptoms
Evidence on the use of progesterone in menopausal hormone therapy
HRT and breast cancer risk - Fast facts
HRT Myths Uncovered - Primary Care Women's Health Forum - May-2018
Menopausal hormone therapy: a better and safer future
The dangers of compounded bioidentical hormone replacement therapy
The impact of micronized progesterone on breast cancer risk: a systematic review
The role of medications in successful aging
What's new in hormone replacement therapy: focus on transdermal estradiol and micronized progesterone
Testosterone
Androgen therapy in women, beyond libido
BMS Testosterone replacement in menopause
Easy HRT prescribing guide 2020
Global Consensus Position Statement on the Use of Testosterone Therapy for Women
International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women
NICE: Menopause Full guideline
Should we be prescribing testosterone to perimenopausal and menopausal women?
Testosterone therapy in women: myths and misconceptions
The testosterone prescribing practice of BMS menopause specialists
Contraception
Contraception for women over the age of 40
FSRH: Intrauterine Contraception
Overview of perimenopausal contraception
Perimenopausal hormonal contraception--can we do better?
GSM
Breast Cancer, Endometrial Cancer, and Cardiovascular Events in Participants who used Vaginal Estrogen in the Women's Health Initiative Observational Study
Estradiol absorption from vaginal tablets in postmenopausal women
Genitourinary syndrome of menopause. Prevalence and quality of life in Spanish postmenopausal women. The GENISSE study
Guidance on diagnosis and management of Urogenital atrophy or Genitourinary Syndrome of the Menopause (GSM)
Treating vulvovaginal atrophy/genitourinary syndrome of menopause: how important is vaginal lubricant and moisturizer composition?
Treatment of moderate to severe dyspareunia with intravaginal prasterone therapy: a review
Vaginal administration of estradiol: effects of dose, preparation and timing on plasma estradiol levels
Vaginal Health: Insights, Views & Attitudes (VIVA) - results from an international survey
Vaginal lubricants and moisturizers: a review into use, efficacy, and safety
What should guide our patient management of vulvovaginal atrophy?
Workshop on normal reference ranges for estradiol in postmenopausal women, September 2019, Chicago, Illinois
POI
2016 IMS Recommendations on women's midlife health and menopause hormone therapy
Age at natural menopause and development of chronic conditions and multimorbidity - results from an Australian prospective cohort
Cardiometabolic health in premature ovarian insufficiency
ESHRE guidelines POI
New insights into the diagnosis and management of bone health in premature ovarian insufficiency
Premature ovarian insufficiency: A toolkit for the primary care physician
Premature ovarian insufficiency: an International Menopause Society White Paper
Progress in understanding and management of premature ovarian insufficiency
Sexuality in premature ovarian insufficiency
Tailored hormonal approach in women with premature ovarian insufficiency
The British Menopause Society and Women's Health Concern recommendations on the management of women with premature ovarian insufficiency
Top tips: menopause
Migraine and menopause
2016 IMS Recommendations on women's midlife health and menopause hormone therapy
Evidence on the use of progesterone in menopausal hormone therapy
Genitourinary syndrome of menopause. Prevalence and quality of life in Spanish postmenopausal women. The GENISSE study
The impact of micronized progesterone on the endometrium: a systematic review
Androgen therapy in women, beyond libido
BMS Testosterone replacement in menopause
Safety and efficacy of testosterone for women: a systematic review and meta-analysis of randomised controlled trial data
Testosterone therapy in women: myths and misconceptions
The British Menopause Society and Women's Health Concern recommendations on the management of women with premature ovarian insufficiency
Therapeutic use of testosterone for women
HRT after the menopause in later life
BMS Urogenital atrophy
Breast Cancer, Endometrial Cancer, and Cardiovascular Events in Participants who used Vaginal Estrogen in the Women's Health Initiative Observational Study
Genitourinary syndrome of menopause. Prevalence and quality of life in Spanish postmenopausal women. The GENISSE study
Treatment of moderate to severe dyspareunia with intravaginal prasterone therapy: a review
Breast cancer and VTE
2016 IMS Recommendations on women's midlife health and menopause hormone therapy
BMS Testosterone replacement in menopause
Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis
Hormones and venous thromboembolism among postmenopausal women
Management of Induced Menopause in Gynaecological Cancers and Their Challenges
NICE guideline 2015: Menopause: diagnosis and management
Postmenopausal hormone replacement therapy and cardiovascular disease: the value of transdermal estradiol and micronized progesterone
Postmenopausal Hormone Therapy and Risk of Idiopathic Venous Thromboembolism Results From the E3N Cohort Study
2016 IMS Recommendations on women's midlife health and menopause hormone therapy
Bioidentical Menopausal Hormone Therapy: Registered Hormones (non-oral estradiol?±?progesterone) are
BMJ Editorial Oct 2019: HRT and breast cancer risk
Custom-compounded bioidentical hormone therapy: why so popular despite potential harm? The case agai
HRT and breast cancer risk We must prevent another setback in women’s health. Rymer J, Brian K, Rega
NICE guideline 2015: Menopause: diagnosis and management
The impact of micronized progesterone on breast cancer risk: a systematic review
Unequal Risks for Breast Cancer Associated with Different Hormone Replacement Therapies: Results fro
A new paper from Professor Robert D Langer demonstrates that WHI Study errors led to 15 years of unnecessary suffering for women
Does hormone replacement therapy cause breast cancer? An application of causal principles to three studies Part 1. The Collaborative Reanalysis
Does hormone replacement therapy cause breast cancer? An application of causal principles to three studies Part 2. The Women’s Health Initiative: estrogen plus progestogen
Does hormone replacement therapy cause breast cancer? An application of causal principles to three studies Part 3. The Women’s Health Initiative: unopposed estrogen
Menopausal Hormone Therapy and Long-term All-Cause and Cause-Specific Mortality The Women’s Health Initiative Randomized Trials
Menopausal hormone therapy: a better and safer future
The evidence base for HRT: what can we believe?
Back to the future: Hormone replacement therapy as part of a prevention strategy for women at the onset of menopause
Endometriosis: seeking optimal management in women approaching menopause
ESHRE guidelines POI
Hormone therapy for preventing cardiovascular disease in post-menopausal women (Review)
Hormones and venous thromboembolism among postmenopausal women
Menopausal hormone therapy: a better and safer future
Menopause and cardiovascular disease
Postmenopausal hormone replacement therapy and cardiovascular disease: the value of transdermal estradiol and micronized progesterone
The impact of micronized progesterone on breast cancer risk: a systematic review
What's new in hormone replacement therapy: focus on transdermal estradiol and micronized progesterone
Diagnostic workup for postmenopausal bleeding: a randomised controlled trial
Unscheduled bleeding on HRT - do we always need to investigate for endometrial pathology?
Podcasts
HRT Prescriptions in England – Dr Sarah Hillman & Dr Louise Newson
Trying to right 20 years of misinformation and hysteria about HRT – Professor Rob Langer
Videos
How the US Government and The Media Conspired to Convince Women That Menopausal Hormone Therapy Was Dangerous
Booklets & Fact sheets
HRT
- Breast Cancer: Risk factors
Menopause at work: a survey to look at the impact of menopausal and perimenopausal symptoms upon women in the workplace.
Understanding the risks of breast cancer (Women’s Health Concern) Infograph - An example of a Menopause Symptom Questionnaire - Initial Presentation
Greene Climacteric Scale - Understanding the risks of breast cancer - Women's Health Concern Infographic
- Ten Tips for Prescribing HRT Remotely
Understanding the risks of breast cancer (Women’s Health Concern) Infograph - BNF NICE - Progesterone
- 10 Top Tips on Testosterone Use for Women
- An example of a Menopause Symptom Questionnaire - Initial Presentation
- NICE: Menopause Full guideline
- International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women
- BMS: HRT Guide
Familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancer
NICE: Familial breast cancer - 2016 IMS Recommendations on women's midlife health and menopause hormone therapy
- ESHRE guidelines POI
- Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and the North American Menopause Society
- Position Statement for Management of Genitourinary Syndrome of the Menopause (GSM)
- Module: Contraception in Women Over 40
Journal publications
Menopause and perimenopause
2016 IMS Recommendations on women's midlife health and menopause hormone therapy
Bioidentical Menopausal Hormone Therapy: Registered Hormones (non-oral estradiol?±?progesterone) are
BMS and WHC 2016 recommendations on HRT in menopausal women
Consensus statement for non-hormonal based treatments for menopausal symptoms
Dietary intake and menopausal symptoms in postmenopausal women: a systematic review
Effectiveness of transdermal oestradiol and natural micronised progesterone for menopausal symptoms
EMAS position statement: Non-hormonal management of menopausal vasomotor symptoms
Menopause Diagnosis and Management - NICE Guideline NG23
The effects of menopause transition on women’s economic participation in the UK
Work outcomes in midlife women: the impact of menopause, work stress and working environment
Breast cancer risk
HRT and breast cancer risk
HRT and breast cancer risk - Fast facts
HRT Myths Uncovered - Primary Care Women's Health Forum - May-2018
HRT optimization, using transdermal estradiol plus micronized progesterone, a safer HRT
Managing vasomotor symptoms effectively without hormones
Menopausal hormone therapy: a better and safer future
Menopause Diagnosis and Management - NICE Guideline NG23
Postmenopausal hormone replacement therapy and cardiovascular disease: the value of transdermal estradiol and micronized progesterone The impact of micronized progesterone on breast cancer risk: a systematic review
Use of hormone replacement therapy and risk of venous thromboembolism: nested case-control studies using the QR esearch and CPRD databases
Prescribing
Bioidentical Menopausal Hormone Therapy: Registered Hormones (non-oral estradiol?±?progesterone) are
BMS - Consensus statement: Bioidentical HRT
Custom-compounded bioidentical hormone therapy: why so popular despite potential harm? The case against routine use
Easy HRT prescribing guide 2020
Effectiveness of transdermal oestradiol and natural micronised progesterone for menopausal symptoms
Evidence on the use of progesterone in menopausal hormone therapy
HRT and breast cancer risk - Fast facts
HRT Myths Uncovered - Primary Care Women's Health Forum - May-2018
Menopausal hormone therapy: a better and safer future
The dangers of compounded bioidentical hormone replacement therapy
The impact of micronized progesterone on breast cancer risk: a systematic review
The role of medications in successful aging
What's new in hormone replacement therapy: focus on transdermal estradiol and micronized progesterone
Testosterone
Androgen therapy in women, beyond libido
BMS Testosterone replacement in menopause
Easy HRT prescribing guide 2020
Global Consensus Position Statement on the Use of Testosterone Therapy for Women
International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women
NICE: Menopause Full guideline
Should we be prescribing testosterone to perimenopausal and menopausal women?
Testosterone therapy in women: myths and misconceptions
The testosterone prescribing practice of BMS menopause specialists
Contraception
Contraception for women over the age of 40
FSRH: Intrauterine Contraception
Overview of perimenopausal contraception
Perimenopausal hormonal contraception--can we do better?
GSM
Breast Cancer, Endometrial Cancer, and Cardiovascular Events in Participants who used Vaginal Estrogen in the Women's Health Initiative Observational Study
Estradiol absorption from vaginal tablets in postmenopausal women
Genitourinary syndrome of menopause. Prevalence and quality of life in Spanish postmenopausal women. The GENISSE study
Guidance on diagnosis and management of Urogenital atrophy or Genitourinary Syndrome of the Menopause (GSM)
Treating vulvovaginal atrophy/genitourinary syndrome of menopause: how important is vaginal lubricant and moisturizer composition?
Treatment of moderate to severe dyspareunia with intravaginal prasterone therapy: a review
Vaginal administration of estradiol: effects of dose, preparation and timing on plasma estradiol levels
Vaginal Health: Insights, Views & Attitudes (VIVA) - results from an international survey
Vaginal lubricants and moisturizers: a review into use, efficacy, and safety
What should guide our patient management of vulvovaginal atrophy?
Workshop on normal reference ranges for estradiol in postmenopausal women, September 2019, Chicago, Illinois
POI
2016 IMS Recommendations on women's midlife health and menopause hormone therapy
Age at natural menopause and development of chronic conditions and multimorbidity - results from an Australian prospective cohort
Cardiometabolic health in premature ovarian insufficiency
ESHRE guidelines POI
New insights into the diagnosis and management of bone health in premature ovarian insufficiency
Premature ovarian insufficiency: A toolkit for the primary care physician
Premature ovarian insufficiency: an International Menopause Society White Paper
Progress in understanding and management of premature ovarian insufficiency
Sexuality in premature ovarian insufficiency
Tailored hormonal approach in women with premature ovarian insufficiency
The British Menopause Society and Women's Health Concern recommendations on the management of women with premature ovarian insufficiency
Top tips: menopause
Migraine and menopause
2016 IMS Recommendations on women's midlife health and menopause hormone therapy
Evidence on the use of progesterone in menopausal hormone therapy
Genitourinary syndrome of menopause. Prevalence and quality of life in Spanish postmenopausal women. The GENISSE study
The impact of micronized progesterone on the endometrium: a systematic review
Androgen therapy in women, beyond libido
BMS Testosterone replacement in menopause
Safety and efficacy of testosterone for women: a systematic review and meta-analysis of randomised controlled trial data
Testosterone therapy in women: myths and misconceptions
The British Menopause Society and Women's Health Concern recommendations on the management of women with premature ovarian insufficiency
Therapeutic use of testosterone for women
HRT after the menopause in later life
BMS Urogenital atrophy
Breast Cancer, Endometrial Cancer, and Cardiovascular Events in Participants who used Vaginal Estrogen in the Women's Health Initiative Observational Study
Genitourinary syndrome of menopause. Prevalence and quality of life in Spanish postmenopausal women. The GENISSE study
Treatment of moderate to severe dyspareunia with intravaginal prasterone therapy: a review
Breast cancer and VTE
2016 IMS Recommendations on women's midlife health and menopause hormone therapy
BMS Testosterone replacement in menopause
Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis
Hormones and venous thromboembolism among postmenopausal women
Management of Induced Menopause in Gynaecological Cancers and Their Challenges
NICE guideline 2015: Menopause: diagnosis and management
Postmenopausal hormone replacement therapy and cardiovascular disease: the value of transdermal estradiol and micronized progesterone
Postmenopausal Hormone Therapy and Risk of Idiopathic Venous Thromboembolism Results From the E3N Cohort Study
2016 IMS Recommendations on women's midlife health and menopause hormone therapy
Bioidentical Menopausal Hormone Therapy: Registered Hormones (non-oral estradiol?±?progesterone) are
BMJ Editorial Oct 2019: HRT and breast cancer risk
Custom-compounded bioidentical hormone therapy: why so popular despite potential harm? The case agai
HRT and breast cancer risk We must prevent another setback in women’s health. Rymer J, Brian K, Rega
NICE guideline 2015: Menopause: diagnosis and management
The impact of micronized progesterone on breast cancer risk: a systematic review
Unequal Risks for Breast Cancer Associated with Different Hormone Replacement Therapies: Results fro
A new paper from Professor Robert D Langer demonstrates that WHI Study errors led to 15 years of unnecessary suffering for women
Does hormone replacement therapy cause breast cancer? An application of causal principles to three studies Part 1. The Collaborative Reanalysis
Does hormone replacement therapy cause breast cancer? An application of causal principles to three studies Part 2. The Women’s Health Initiative: estrogen plus progestogen
Does hormone replacement therapy cause breast cancer? An application of causal principles to three studies Part 3. The Women’s Health Initiative: unopposed estrogen
Menopausal Hormone Therapy and Long-term All-Cause and Cause-Specific Mortality The Women’s Health Initiative Randomized Trials
Menopausal hormone therapy: a better and safer future
The evidence base for HRT: what can we believe?
Back to the future: Hormone replacement therapy as part of a prevention strategy for women at the onset of menopause
Endometriosis: seeking optimal management in women approaching menopause
ESHRE guidelines POI
Hormone therapy for preventing cardiovascular disease in post-menopausal women (Review)
Hormones and venous thromboembolism among postmenopausal women
Menopausal hormone therapy: a better and safer future
Menopause and cardiovascular disease
Postmenopausal hormone replacement therapy and cardiovascular disease: the value of transdermal estradiol and micronized progesterone
The impact of micronized progesterone on breast cancer risk: a systematic review
What's new in hormone replacement therapy: focus on transdermal estradiol and micronized progesterone
Diagnostic workup for postmenopausal bleeding: a randomised controlled trial
Unscheduled bleeding on HRT - do we always need to investigate for endometrial pathology?
Podcasts
HRT Prescriptions in England – Dr Sarah Hillman & Dr Louise Newson
Trying to right 20 years of misinformation and hysteria about HRT – Professor Rob Langer
Videos
How the US Government and The Media Conspired to Convince Women That Menopausal Hormone Therapy Was Dangerous
NICE
NICE https://www.nice.org.uk/guidance/ng23
NICE Guidelines Shared decision making https://www.nice.org.uk/guidance/ng197/resources/shared-decision-making-pdf-66142087186885
NICE Guidelines Shared decision making https://www.nice.org.uk/guidance/ng197/resources/shared-decision-making-pdf-66142087186885
Womens Health concern
WHC fact sheetswww.womens-health-concern.org/help-and-advice/factsheets/
WHC fact sheets www.womens-health-concern.org/help-and-advice/factsheets/
· The menopause (also available in Bulgarian, Lithuanian, Polish, Romanian and Spanish)
· Induced menopause in women with endometriosis (PDF)
· HRT
· HRT: The history
· HRT: Benefits and risks
· HRT: Summary
· HRT: Types, doses and regimens
· Testosterone for women
· Breast cancer risk factors
· Complementary/alternative therapies for menopausal women
· Cognitive Behaviour Therapy (CBT) for Menopausal Symptoms
· Contraception for the older woman
· Postmenopausal bleeding
· Prolapse: Uterine and vaginal
· Urogenital problems
· Vaginal dryness
· Osteoporosis: bone health following the menopause
· Menopause and insomnia
· Migraine and HRT
· Menopausal hair loss
Other gynaecological and sexual health issues·
WHC fact sheets www.womens-health-concern.org/help-and-advice/factsheets/
· The menopause (also available in Bulgarian, Lithuanian, Polish, Romanian and Spanish)
· Induced menopause in women with endometriosis (PDF)
· HRT
· HRT: The history
· HRT: Benefits and risks
· HRT: Summary
· HRT: Types, doses and regimens
· Testosterone for women
· Breast cancer risk factors
· Complementary/alternative therapies for menopausal women
· Cognitive Behaviour Therapy (CBT) for Menopausal Symptoms
· Contraception for the older woman
· Postmenopausal bleeding
· Prolapse: Uterine and vaginal
· Urogenital problems
· Vaginal dryness
· Osteoporosis: bone health following the menopause
· Menopause and insomnia
· Migraine and HRT
· Menopausal hair loss
Other gynaecological and sexual health issues·
- Abortion
- Bacterial vaginosis
- Breast care and self-examination
- Cervical cancer
- Cervical screening
- Contraception
- Coronary heart disease
- Endometrial ablation
- Endometriosis
- Female incontinence
- Fibroids
- Heavy periods
- Human papilloma virus (HPV)
- Hysterectomy
- Infertility
- Male menopause
- Ovarian cancer
- Ovarian cysts
- Period pain
- Polycystic ovary syndrome (PCOS)
- Premenstrual syndrome (PMS)
- Primary Peritoneal Cancer (PPC)
- Sexually transmitted infections
- Thrush
- Uterine polyps
- Vulval pain